In the context of cancer, ANGPTL2-induced inflammation creates a deleterious environment that favours genomic instability and DNA damage and thus contributes to all stages of tumour development, from initiation to progression [27, 28, 32, 34, 40]. The gene discussed is ANGPTL2; the disease is cancer.